Detalhe da pesquisa
1.
Rambutan genome revealed gene networks for spine formation and aril development.
Plant J
; 108(4): 1037-1052, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34519122
2.
The Pan-Cancer Multi-Omics Landscape of FOXO Family Relevant to Clinical Outcome and Drug Resistance.
Int J Mol Sci
; 23(24)2022 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36555288
3.
Predictive Nomogram of Subsequent Liver Metastasis After Mastectomy or Breast-Conserving Surgery in Patients With Nonmetastatic Breast Cancer.
Cancer Control
; 28: 1073274821997418, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33626925
4.
Diagnostic and prognostic value of circular RNA CDR1as/ciRS-7 for solid tumours: A systematic review and meta-analysis.
J Cell Mol Med
; 24(17): 9507-9517, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32783378
5.
Development and validation of a stromal immune phenotype classifier for predicting immune activity and prognosis in triple-negative breast cancer.
Int J Cancer
; 147(2): 542-553, 2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32285442
6.
circRAD18 sponges miR-208a/3164 to promote triple-negative breast cancer progression through regulating IGF1 and FGF2 expression.
Carcinogenesis
; 40(12): 1469-1479, 2019 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31001629
7.
Pan-Cancer Single-Cell and Spatial-Resolved Profiling Reveals the Immunosuppressive Role of APOE+ Macrophages in Immune Checkpoint Inhibitor Therapy.
Adv Sci (Weinh)
; : e2401061, 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38569519
8.
PIWI-interacting RNA-YBX1 inhibits proliferation and metastasis by the MAPK signaling pathway via YBX1 in triple-negative breast cancer.
Cell Death Discov
; 10(1): 7, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38182573
9.
Circular RNA: A promising new star of vaccine.
J Transl Int Med
; 11(4): 372-381, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38130633
10.
Dissection of FOXO1-Induced LYPLAL1-DT Impeding Triple-Negative Breast Cancer Progression via Mediating hnRNPK/ß-Catenin Complex.
Research (Wash D C)
; 6: 0289, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38111678
11.
Dissecting the role of cancer-associated fibroblast-derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single-cell transcriptomic study.
Clin Transl Med
; 13(2): e1189, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36772945
12.
Novel Implication of the Basement Membrane for Breast Cancer Outcome and Immune Infiltration.
Int J Biol Sci
; 19(5): 1645-1663, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37056938
13.
AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer.
Cell Death Dis
; 14(12): 790, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38040691
14.
Comprehensive metabolome and transcriptome analyses demonstrate divergent anthocyanin and carotenoid accumulation in fruits of wild and cultivated loquats.
Front Plant Sci
; 14: 1285456, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37900735
15.
Integrative mRNA and Long Noncoding RNA Analysis Reveals the Regulatory Network of Floral Bud Induction in Longan (Dimocarpus longan Lour.).
Front Plant Sci
; 13: 923183, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35774802
16.
Establishment of a Cell Necroptosis Index to Predict Prognosis and Drug Sensitivity for Patients With Triple-Negative Breast Cancer.
Front Mol Biosci
; 9: 834593, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35601830
17.
Turning up a new pattern: Identification of cancer-associated fibroblast-related clusters in TNBC.
Front Immunol
; 13: 1022147, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36275659
18.
Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer.
Oncoimmunology
; 11(1): 2020984, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35003899
19.
N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer.
Nat Commun
; 13(1): 2672, 2022 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35562334
20.
Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery.
Int J Surg
; 107: 106936, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36341760